JNK-IN-15, Cell-Permeable, Negative Control
JNK-IN-15, Cell-Permeable, Negative Control is a negative control of JNK-IN-15, Cell-Permeable. JNK-IN-15, Cell-Permeable is an inhibitor of JNK[1].
Product Specifications
UNSPSC
12352209
Target
JNK
Type
Peptides
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jnk-in-15-cell-permeable-negative-control.html
Solubility
10 mM in DMSO
Smiles
O=C(CCCNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC(C)=O)CC1=CC=C(O)C=C1)=O)=O)CCCNC(N)=N)=O)CCCCN)=O)CCCCN)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)CC4=CNC=N4)=O)CCCCN)=O)CC(C)C)=O)CCCCN)=O)CC(N)=O)=O)CCC(N)=O)=O)C)=O)CC(C)C)=O)CO)=O)CCCCN)=O)CCC3)=O)CCSC)=O)CC(C)C)=O)[C@@H](C)O)=O)CCC2)=O)CC(C)C)=O)C(C)C)=O)=O)CCCNC(N)=N)=O)[C@H](CC)C)=O)CC(C)C)=O)CC(N)=O)=O)CO)=O)CC(O)=O
Molecular Formula
C191H336N70O48S
Molecular Weight
4413.22
References & Citations
[1]Guha I, et al. The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons. Neurobiol Aging. 2016 Oct;46:138-48.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B275352-1MG 1 mg
Benzyl (2R)-3-N,N-Dibenzylamino-2-fluoropropanoate-13C3
Sign In for Pricing
View Details 
LC421985 20 µg
Nucleophosmin (NPM1) (NM_001037738) Human Over-expression Lysate
Sign In for Pricing
View Details 